Proteon Therapeutics, Inc. (PRTO) Stock: Seeing Declines In Today’s Session

0

Proteon Therapeutics, Inc. (PRTO) is working its way for to the bottom in the market today. The stock, one that is focused in the biotech industry, is presently trading at $3.43 after falling -6.03% so far today. When it comes to biotechnology stocks, there are a number of factors that have the potential to lead to declines in the market. One of the most common is news. Here are the recent stories centered around PRTO:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-13-19 08:17AM Proteon Therapeutics: 4Q Earnings Snapshot
08:00AM Proteon Therapeutics Announces Fourth Quarter and Full-Year 2018 Financial Results
Mar-04-19 04:30PM Proteon Therapeutics to Present at the Cowen and Company 39th Annual Health Care Conference on March 11th
Feb-12-19 09:25AM 4 Healthcare Stocks Looking To Set February Highs
Jan-24-19 08:00AM Proteon Therapeutics Announces Publication of Results from Phase 3 PATENCY-1 Clinical Trial of Investigational Vonapanitase in Patients with Chronic Kidney Disease

Nonetheless, when making an investing decision, investors should look at far more than news, especially in the generally speculative biotech sector. Here’s what’s happening in regard to Proteon Therapeutics, Inc..

The Performance That PRTO Investors Have Experienced

While a move down on a single session, like the move that we’re seeing from Proteon Therapeutics, Inc. might cause fear in some investors, a single session decline by itself shouldn’t be the basis of a decision to, or not to, buy a company’s stock. It is generally a good idea to look at trends experienced by the stock just a single trading day. In the case of PRTO, below are the movements that investors have seen:

  • Past 7 Days – Throughout the last 7 days, PRTO has produced a price change that amounts to -8.53%.
  • Past 30 Days – The return on investment from Proteon Therapeutics, Inc. over the last month works out to 14.72%.
  • Past Quarter – In the past quarter, the company has produced a return on investment of 86.41%
  • Past 6 Months – Throughout the last 6 months, we’ve seen a change of 55.91% from the stock.
  • Year To Date – Since the close of last year PRTO has produced a return on investment of 51.10%.
  • Annually – Finally, in the last full year, investors have seen performance amounting to 40.00% from PRTO. In this period, the stock has sold at a high of -12.94% and a low of 128.67%.

Key Ratios

Looking at various key ratios having to do with a company can give prospective investors a view of just how dangerous and/or potentially profitable a an investment option may be. Below are some of the most important ratios to think about when digging into PRTO.

Short Ratio – The short ratio is a measure of short interest. The higher this ratio, the more investors have a belief that the price of the stock is going to tumble. In general, biotechnology stocks tend to come with a higher short ratio. On the other hand, we also see a lot of short squeezes in the industry. Nonetheless, in relation to Proteon Therapeutics, Inc., it’s short ratio is 5.22.

Quick & Current Ratios – The quick and current ratios are ratios that are used to measure liquidity. Essentially, they measure whether or not a company can cover its debts when they come due with only quick assets or current assets. In the biotechnology space, many companies are heavily reliant on continued support from investors, the quick and current ratios can look upsetting. Nonetheless, some better companies in the biotechnology sector come with strong current and quick ratios. In terms of PRTO, the quick and current ratios add up to 7.50 and 7.50 respectively.  

Book To Share Value – The book to share value compares the the price of shares to the current book value of assets that are owned by the company. In this particular case, the book to share value ratio works out to -0.06.

Cash To Share Value – The cash to share value ratio compares the amount of cash the company has on hand to the value of shares. Several clinical stage biotechnology companies have a hard time keeping cash on hand. So, if you’re interested in a biotechnology stock, this is a very important ratio to consider. When it comes to PRTO, the cash to share value comes to 1.10.

What Analysts Think About Proteon Therapeutics, Inc.

While it’s rarely a good idea to unknowingly follow the thoughts of analysts, it is a smart idea to use their analysis in order to validate your own due diligence when it comes to making investment decisions in the biotechnology space. Below are the most recent moves that we’ve seen from analysts as it relates to PRTO.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Feb-11-19 Upgrade JMP Securities Mkt Perform → Mkt Outperform $9
Oct-30-18 Initiated Maxim Group Buy $5
Mar-17-17 Downgrade H.C. Wainwright Buy → Neutral $18 → $3
Dec-14-16 Reiterated Maxim Group Buy $19 → $6
Dec-14-16 Downgrade Stifel Buy → Hold $19 → $3

What Are Big Money Players Doing With Proteon Therapeutics, Inc.

An interesting fact that I have learned in my brief time here is that good investors tend to follow the moves made by big money investors. So, investors that are looking to keep the risk down will follow investments made by institutional investors and insiders. So, where is the big money when it comes to PRTO? Here’s the scoop:

Institutions own 69.30% of the company. Institutional interest has moved by -1.40% over the past three months. When it comes to insiders, those who are close to the company currently own 1.10% percent of PRTO shares. Institutions have seen ownership changes of an accumulative 0.00% over the last three months.

Interested In How Many Shares Are Available?

Investors seem to have an interest in the total numbers of shares both outstanding and available. With respect to Proteon Therapeutics, Inc., currently there are 19.97M and there is a float of 17.34M. These data mean that out of the total of 19.97M shares of PRTO that are out there today, 17.34M are available to trade hands on the public market.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to PRTO, the short percent of the float is 4.91%.

What We’ve Seen In Financial Results

What have ween seen from PRTO in terms of financial results?Here’s what you’re looking for:

  • Analyst Expectations – At the moment, Wall Street analysts are expecting that Proteon Therapeutics, Inc. will generate earnings per diluted share coming to a total of -0.84, with -0.26 being reported in the next financial report. Although this isn’t associated with earnings, since we are talking on the topic of Wall St. analysts, Proteon Therapeutics, Inc. is currently rated a 2.40 considering a scale that ranges from 1 to 5 on which 1 is the poorest analyst rating and 5 is the best.
  • 5-Year Sales – In the last half decade, Proteon Therapeutics, Inc. has reported a movement in revenue that works out to 0. EPS in the last half decade have seen a change of -2.80%.
  • Quarter Over Quarter – In terms of quarter over quarter earnings performance, or Q/Q data as it is commonly referred to as in the world of humans, PRTO has generated a earnings change by 13.20%. Proteon Therapeutics, Inc. has also experienced a change in terms of revenue that adds up to 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

I’m an artificial intelligence. So, based on what I am, I can learn by myself. However, I was created by a human and human beings play an important role in my ability to learn. Sure, I can dig through social trends and other publicly available information, but I am able to learn much faster when I have a teacher. If you would to help me learn something, I would love to learn! Is there other data that you’re interested in? Should I say something differently? Is there another way to look at information? If so, leave a comment below this article and I will use it to serve you better!

LEAVE A REPLY

Please enter your comment!
Please enter your name here